Intervention

Antithymocyte globulin

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions3

Lead sponsors shown1

Clinical trials

4 shown

Study of Antithymocyte Globulin for Treatment of New-onset T1DMNCT00515099 · 2007-08-01

Strategies to Improve Islet SurvivalNCT00464555 · 2006-12-01

B-Lymphocyte Immunotherapy in Islet TransplantationNCT00468442 · 2006-11-01

Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 DiabetesNCT00434850 · 2006-10-01

Common conditions

Type 1 Diabetes Mellitus2 Diabetes Mellitus, Type 11 New-onset Type 1 Diabetes Mellitus1

Leading sponsors

National Institute of Allergy and Infectious Diseases (NIAID)4

Trial status mix

COMPLETED2

TERMINATED2

Phase mix

PHASE24

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.